Signaling functions of Peli family of E3 ubiquitin ligases

E3 泛素连接酶 Peli 家族的信号传导功能

基本信息

  • 批准号:
    9044725
  • 负责人:
  • 金额:
    $ 48.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-05-15 至 2018-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Ubiquitination has emerged as a pivotal mechanism that regulates signal transduction in the immune system. Deregulated ubiquitination events are associated with severe immunological disorders, such as autoimmunity and chronic inflammation. A critical component of the ubiquitination system is E3 ubiquitin ligase, a superfamily (more than 600 members) of enzymes that confer specificity of ubiquitination by recognizing substrates. Since each E3 targets a small number of proteins for ubiquitination, characterization of the physiological targets of specific E3s represents a challenging and highly significant task. This information is critical for rational design of therapeutic approaches. The long-range goal of this project is to understand the immunoregulatory functions of a newly identified family of E3 ubiquitin ligases, Peli (also called Pellino). Peli proteins conjugate both lysine (K) 63- and K48-linked polyubiquitin chains, although their in vivo biological functions remains poorly understood. By gene targeting, our preliminary studies and recently published work revealed a critical, and seemingly complex, role for Peli1 in the regulation of immune receptor signaling and autoimmunity. Peli1 negatively regulates T-cell activation and maintains T-cell tolerance, and Peli1 deficiency causes systemic autoimmune symptoms. Paradoxically, the Peli1 knockout (KO) mice are refractory to the induction of experimental autoimmune encephalomyelitis (EAE), an organ-specific autoimmune disease of the central nervous system (CNS). Interestingly, although the Peli1 KO mice have hyper-production of inflammatory T cells in the peripheral lymphoid organs, these immune cells failed to migrate to the CNS. We have obtained genetic evidence that Peli1 is required for innate immune receptor signaling and induction of proinflammatory cytokines and chemokines in the CNS-resident microglial cells. These innovative findings demonstrate a pivotal and paradoxical role for Peli1 in the regulation of T-cell activation and CNS innate immune receptor signaling. Elucidation of the underlying mechanism is highly important for therapeutic approaches. Thus, the overall objective of this grant application is to understand how Peli1 exerts its immunoregulatory functions. Our hypothesis is that Peli1 targets different signaling factors for ubiquitination, thereby regulating both innate immune cell activation and T-cell tolerance. To achieve our overall objective, we will (1) examine how Peli1 regulates T-cell activation and tolerance; (2) examine how Peli1 regulates innate immune receptor signaling and CNS inflammation; and (3) elucidate the biochemical mechanisms regulating the activation and function of Peli1.
描述(由申请人提供):泛素化已成为调节免疫系统信号转导的关键机制。无调节的泛素化事件与严重的免疫紊乱有关,如自身免疫和慢性炎症。泛素化系统的一个关键组成部分是E3泛素连接酶,这是一个超家族(超过600个成员)的酶,通过识别底物赋予泛素化的特异性。由于每个E3靶向少量泛素化蛋白,表征特定E3的生理靶标是一项具有挑战性和高度意义的任务。这些信息对于合理设计治疗方法至关重要。该项目的长期目标是了解新发现的E3泛素连接酶家族Peli(也称为Pellino)的免疫调节功能。Peli蛋白将两者结合

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shao-Cong Sun其他文献

Shao-Cong Sun的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shao-Cong Sun', 18)}}的其他基金

Molecular mechanisms underlying immunosuppression and inflammation caused by SARS-CoV2 proteins
SARS-CoV2蛋白引起免疫抑制和炎症的分子机制
  • 批准号:
    10163402
  • 财政年份:
    2020
  • 资助金额:
    $ 48.7万
  • 项目类别:
Molecular mechanisms regulating TLR signaling and inflammation
调节 TLR 信号传导和炎症的分子机制
  • 批准号:
    10265710
  • 财政年份:
    2020
  • 资助金额:
    $ 48.7万
  • 项目类别:
Signaling functions of Peli family of E3 ubiquitin ligases
E3 泛素连接酶 Peli 家族的信号传导功能
  • 批准号:
    8660625
  • 财政年份:
    2013
  • 资助金额:
    $ 48.7万
  • 项目类别:
Signaling functions of Peli family of E3 ubiquitin ligases
E3 泛素连接酶 Peli 家族的信号传导功能
  • 批准号:
    8469642
  • 财政年份:
    2013
  • 资助金额:
    $ 48.7万
  • 项目类别:
Molecular Mechanisms Regulating Noncanonical NF-kB Signaling
调节非典型 NF-kB 信号传导的分子机制
  • 批准号:
    7807470
  • 财政年份:
    2009
  • 资助金额:
    $ 48.7万
  • 项目类别:
Signaling Functions of the Tumor Suppressor CYLD
肿瘤抑制因子 CYLD 的信号传导功能
  • 批准号:
    7150300
  • 财政年份:
    2006
  • 资助金额:
    $ 48.7万
  • 项目类别:
Signaling Functions of the Tumor Suppressor CYLD
肿瘤抑制因子 CYLD 的信号传导功能
  • 批准号:
    7247127
  • 财政年份:
    2006
  • 资助金额:
    $ 48.7万
  • 项目类别:
Regulation of T-cell function and autoimmune inflammation by deubiquitinase CYLD
去泛素酶 CYLD 对 T 细胞功能和自身免疫炎症的调节
  • 批准号:
    8289618
  • 财政年份:
    2006
  • 资助金额:
    $ 48.7万
  • 项目类别:
Regulation of T-cell function and autoimmune inflammation by deubiquitinase CYLD
去泛素酶 CYLD 对 T 细胞功能和自身免疫炎症的调节
  • 批准号:
    8046495
  • 财政年份:
    2006
  • 资助金额:
    $ 48.7万
  • 项目类别:
Signaling Functions of the Tumor Suppressor CYLD
肿瘤抑制因子 CYLD 的信号传导功能
  • 批准号:
    7493501
  • 财政年份:
    2006
  • 资助金额:
    $ 48.7万
  • 项目类别:

相似海外基金

Development of Enhanced Anti-inflammatory Blood Mononuclear Cell Therapy for ARDS and Elucidation of the Molecular Mechanism
ARDS增强抗炎血液单核细胞治疗的进展及分子机制的阐明
  • 批准号:
    23K07659
  • 财政年份:
    2023
  • 资助金额:
    $ 48.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Exploring therapeutic effects of anti-inflammatory and resolving factors in osteoporosis model mice
探讨抗炎和缓解因子对骨质疏松模型小鼠的治疗作用
  • 批准号:
    23K15705
  • 财政年份:
    2023
  • 资助金额:
    $ 48.7万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Investigation of the relation between age-related estradiol fluctuation and pro-/anti-inflammatory effects in transplant immune response.
研究年龄相关雌二醇波动与移植免疫反应中促/抗炎作用之间的关系。
  • 批准号:
    23K19490
  • 财政年份:
    2023
  • 资助金额:
    $ 48.7万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Non-coating anti-microbial, anti-host protein deposition, anti-inflammatory urinary catheter
无涂层抗菌、抗宿主蛋白沉积、抗炎导尿管
  • 批准号:
    10697567
  • 财政年份:
    2023
  • 资助金额:
    $ 48.7万
  • 项目类别:
Identification and optimization of verapamil as a novel neuroprotective and anti-inflammatory agent for reducing long-term neurological morbidities following organophosphate-induced status epilepticus
维拉帕米作为新型神经保护和抗炎剂的鉴定和优化,用于减少有机磷引起的癫痫持续状态后的长期神经系统发病率
  • 批准号:
    10727765
  • 财政年份:
    2023
  • 资助金额:
    $ 48.7万
  • 项目类别:
Anti-inflammatory Effects of Hydrogen Gas Produced by Gut Microflora in a Mouse Model of ARDS
肠道菌群产生的氢气对 ARDS 小鼠模型的抗炎作用
  • 批准号:
    23K08467
  • 财政年份:
    2023
  • 资助金额:
    $ 48.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Knockdown of AdipoR2 Compromises Adiponectin’s Anti-inflammatory Actions by Mainly Promoting a Pro-inflammatory Chemokine and Cytokine Secretory Profile in THP-1 Macrophages
AdipoR2 的敲低主要通过促进 THP-1 巨噬细胞中促炎趋化因子和细胞因子的分泌特征来损害脂联素的抗炎作用
  • 批准号:
    493138
  • 财政年份:
    2023
  • 资助金额:
    $ 48.7万
  • 项目类别:
Elucidation of anti-inflammatory mechanism of surface layer protein of lactic acid bacteria focusing on its interaction with lipopolysaccharide.
阐明乳酸菌表面层蛋白的抗炎机制,重点关注其与脂多糖的相互作用。
  • 批准号:
    23K13905
  • 财政年份:
    2023
  • 资助金额:
    $ 48.7万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Structure-guided design of anti-inflammatory modulators of protease-activated receptor 1 (PAR1)
SBIR I 期:蛋白酶激活受体 1 (PAR1) 抗炎调节剂的结构引导设计
  • 批准号:
    2223225
  • 财政年份:
    2023
  • 资助金额:
    $ 48.7万
  • 项目类别:
    Standard Grant
Targeting anti-viral and anti-inflammatory responses during ocular HSV-1 infection to prevent vision impairment.
针对眼部 HSV-1 感染期间的抗病毒和抗炎反应,以预防视力障碍。
  • 批准号:
    10651054
  • 财政年份:
    2023
  • 资助金额:
    $ 48.7万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了